NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/09/2024
Voltar para busca
Dado oficial do USPTO
IBIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
20
Atualização mais recente
24/09/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
42
Data de depósito
19/07/2023
Data de registro
24/09/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/09/2024
Última transação
24/09/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
11/07/2023
Primeiro uso no comércio
11/07/2023
Código do desenho
3
Tipo de titular
03
Localização do titular
San Diego, CA
Examinador
BONEN-CLARK, HOPE
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of stylized word "IBIO", with the dot in the second "I" in the form of a double helix forming an infinity image, with arrow images in the interior of one side of the infinity form, and an image of carbons inside the other side of the infinity image.
Titulares e representantes
Titulares
iBio, Inc
Representantes
Daniel Chalker CHALKER FLORES, LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Pharmaceutical peptideproteinantibodychimeric antibody or protein drug development services; Pharmaceutical peptideproteinantibodychimeric antibodies or proteins product development; Pharmaceutical research and development of peptidesproteinsantibodieschimeric antibodies or proteins; Conducting early evaluations in the field of new peptideproteinantibodychimeric antibody or protein based pharmaceuticals; Development of peptideproteinantibodychimeric antibody or protein based pharmaceutical preparations and medicines; Laboratory peptide and protein based research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development of peptideproteinantibodychimeric antibody or protein based pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of peptideproteinantibodychimeric antibody or protein based pharmaceuticals; Research on the subject of peptideproteinantibodychimeric antibody or protein based pharmaceuticals; Technical research in the field of peptideproteinantibodychimeric antibody or protein based pharmaceutical studies; Testinginspection or research of pharmaceuticalscosmetics or foodstuff made with peptidesproteinsantibodieschimeric antibodies or proteins; Research and development in the pharmaceutical and biotechnology fields; Research and development regarding pharmaceuticalsproteinsantibodies; platform-as-a-service (PaaS) featuring computer software platforms for protein analysis and discovery of antibody-based drugs; Software as a service (SAAS) services featuring software for designing molecule libraries for the purposes of generating products in the field of pharmaceuticalsbiotechnologymedicine; Computer software development in the field of artificial intelligencebiotechnologypharmaceuticalsmedical applications; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing on-line non-downloadable software using artificial intelligence for use in facilitating product development in the field of biotechnologypharmaceuticalsmedicine; Scientific research for medical purposes in the area of cancerous diseases; Software as a service (SAAS) services featuring software using artificial intelligence for use in facilitating product development in the field of biotechnologypharmaceuticalsmedicine; Technical consulting in the field of pharmaceutical studies; Technology consultation in the field of artificial intelligence; Testing of pharmaceuticals; Testinginspection or research of pharmaceuticalscosmetics or foodstuff; Providing medical testing services and information in the field of cancer research and disease classification; Providing information about medical research in the field of artificial intelligencemedical biotechnologypharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
20 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
24/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/07/2024
PUBO
PUBLISHED FOR OPPOSITION
09/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/04/2024
GNRT
NON-FINAL ACTION E-MAILED
08/04/2024
CNRT
NON-FINAL ACTION WRITTEN
08/04/2024
DOCK
ASSIGNED TO EXAMINER
25/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/12/2023
ALIE
ASSIGNED TO LIE
28/12/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
18/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/08/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
01/08/2023
NWAP
NEW APPLICATION ENTERED
22/07/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace IBIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.